{"meta":{"query_hash":"55d1ad80bcaf","filters":{"venue":"Cardiovascular Drug Reviews"},"cohort_total":9,"direct_labels_cover":0,"predictions_cover":9,"exported":9,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/55d1ad80bcaf","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cardiovascular+Drug+Reviews"},"results":[{"id":"W2005112720","doi":"10.1111/j.1527-3466.2006.00033.x","title":"C‐Reactive Protein (CRP)‐Lowering Agents","year":2006,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":277,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Fosinopril; Pharmacology; Fenofibrate; Ramipril; Internal medicine; Atorvastatin; Valsartan; Endocrinology; Telmisartan; Angiotensin-converting enzyme; Blood pressure","score_opus":0.04918002938480468,"score_gpt":0.3189137343322651,"score_spread":0.2697337049474604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005112720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01777424,0.813007,0.009578036,0.012681167,0.008001821,0.0010954157,0.0040613357,0.0022811007,0.13151984],"genre_scores_gemma":[0.2651598,0.51569283,0.022013474,0.038156576,0.010209254,0.0028575321,0.009427388,0.0003017561,0.13618138],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824786,0.0004546889,0.00019857315,0.00018297446,0.000704752,0.00021113263],"domain_scores_gemma":[0.9992793,0.00011408828,0.00016757006,0.000054188702,0.00029717622,0.00008758872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007701093,0.0009289799,0.00126669,0.00073690136,0.00038980614,0.0006969469,0.0008944068,0.0011417418,0.01479843],"category_scores_gemma":[0.0017236826,0.00016409546,0.00075319636,0.0007850074,0.00022325283,0.00035003756,0.0005144059,0.0018589852,0.009442072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024533954,0.0013256297,0.002064523,0.0055473363,0.0005197301,0.001161902,0.00006871638,0.0002749207,0.023161763,0.0026346352,0.24651174,0.7142758],"study_design_scores_gemma":[0.00085802504,0.0014762742,0.005239153,0.0014415196,0.00022478367,0.0020550166,0.000034846915,0.00018917765,0.007962604,0.0011247982,0.9793569,0.0000369405],"about_ca_topic_score_codex":0.0008335543,"about_ca_topic_score_gemma":0.0008656428,"teacher_disagreement_score":0.01479843,"about_ca_system_score_codex":0.00041385883,"about_ca_system_score_gemma":0.00054506253,"threshold_uncertainty_score":0.04950571},"labels":[],"label_agreement":null},{"id":"W2035657173","doi":"10.1111/j.1527-3466.2000.tb00045.x","title":"Ridogrel: An Antiplatelet Agent with Antihypertensive Properties","year":2000,"lang":"en","type":"article","venue":"Cardiovascular Drug Reviews","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Thromboxane; Antithrombotic; Losartan; Pharmacology; Aspirin; Medicine; Thromboxane-A synthase; Platelet; Thromboxane A2; Thromboxane receptor; Ex vivo; In vivo; Angiotensin II; Receptor; Chemistry; Internal medicine; In vitro; Biochemistry; Biology","score_opus":0.02880990748899466,"score_gpt":0.23485040891820488,"score_spread":0.2060405014292102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035657173","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47652608,0.43694702,0.0061416733,0.0054361043,0.0021887107,0.00035721084,0.0021665944,0.001654792,0.06858177],"genre_scores_gemma":[0.83396524,0.12923624,0.0055761994,0.004962484,0.0017774303,0.0001360879,0.0022868258,0.000039531384,0.022019945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999931,0.00001612851,0.000010745953,0.000008789305,0.000020183568,0.000013240988],"domain_scores_gemma":[0.99994075,0.000007711721,0.0000116857345,0.0000038726153,0.000010506861,0.000025441364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015298263,0.00032742662,0.00042808417,0.0004649621,0.00017127585,0.00026567726,0.00023159897,0.00046381407,0.0032561587],"category_scores_gemma":[0.00015795005,0.00009159954,0.00018480765,0.00029028454,0.00008760954,0.00011304558,0.00013416045,0.00037458667,0.0014962544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060157203,0.0010030752,0.0027227176,0.0039206324,0.0002141479,0.003981667,0.00011447609,0.00028500397,0.32402235,0.0026427966,0.02299064,0.6320869],"study_design_scores_gemma":[0.00952975,0.034686964,0.057691846,0.0006449159,0.0015899214,0.036271624,0.00013316808,0.0010867836,0.20786709,0.0013814236,0.6489891,0.00012744087],"about_ca_topic_score_codex":0.00028415336,"about_ca_topic_score_gemma":0.00051024504,"teacher_disagreement_score":0.0032561587,"about_ca_system_score_codex":0.000076031465,"about_ca_system_score_gemma":0.0001208145,"threshold_uncertainty_score":0.010892987},"labels":[],"label_agreement":null},{"id":"W2038573321","doi":"10.1111/j.1527-3466.2000.tb00049.x","title":"Joint Meeting of American Society for Biochemistry and Molecular Biology, American Society for Pharmacology and Experimental Therapeutics, French Pharmacological Society and Pharmacological Society of Canada Cardiovascular Drugs Boston, MA, USA June 4–8, 2000","year":2000,"lang":"en","type":"article","venue":"Cardiovascular Drug Reviews","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Haven; Medicine; Library science; Gerontology; Computer science","score_opus":0.029115646699854975,"score_gpt":0.3119951194097126,"score_spread":0.2828794727098576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038573321","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061108537,0.16851144,0.014183805,0.19422822,0.25232488,0.0012642923,0.004248348,0.0012207157,0.3029098],"genre_scores_gemma":[0.04367437,0.04278192,0.006416082,0.005497518,0.031892627,0.0003759221,0.0039441274,0.00017293495,0.8652445],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996618,0.00004973115,0.00001894169,0.00007270771,0.00009962268,0.0000972422],"domain_scores_gemma":[0.9991555,0.000055769957,0.000028616534,0.000026337582,0.00042130548,0.0003125389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095366174,0.0016119488,0.0011522745,0.00097351405,0.0013357823,0.0016779788,0.0008561641,0.0023456907,0.055754293],"category_scores_gemma":[0.0008021608,0.00037678477,0.0010168779,0.00041106224,0.00041484906,0.00067687995,0.0008746273,0.003086926,0.02149583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017652153,0.00050973526,0.001200912,0.00039877437,0.00015103757,0.00036587415,0.00009727494,0.00026653067,0.018504394,0.002322755,0.85534316,0.11907432],"study_design_scores_gemma":[0.0002236546,0.00033991717,0.008713851,0.00013331776,0.00010876805,0.0003785673,0.000095593095,0.0006817793,0.0036054892,0.0007072322,0.98498607,0.000025802297],"about_ca_topic_score_codex":0.006163805,"about_ca_topic_score_gemma":0.018422714,"teacher_disagreement_score":0.055754293,"about_ca_system_score_codex":0.0017714738,"about_ca_system_score_gemma":0.0016903388,"threshold_uncertainty_score":0.1865167},"labels":[],"label_agreement":null},{"id":"W2040559995","doi":"10.1111/j.1527-3466.2007.00008.x","title":"Cardiovascular Actions of the Peroxisome Proliferator‐Activated Receptor‐Alpha (PPARα) Agonist Wy14,643","year":2007,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Peroxisome proliferator-activated receptor; Peroxisome proliferator-activated receptor alpha; Peroxisome; Agonist; Peroxisome proliferator; Context (archaeology); Receptor; Endocrinology; PPAR agonist; Alpha (finance); Internal medicine; Medicine; Pharmacology; Lipid metabolism; Nuclear receptor; Biology; Transcription factor; Biochemistry; Surgery","score_opus":0.055644107719236974,"score_gpt":0.31196325153621357,"score_spread":0.2563191438169766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040559995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065419666,0.9955913,0.0003598264,0.0001840195,0.00021865907,0.000007439383,0.000028523944,0.000017139839,0.0029389216],"genre_scores_gemma":[0.0012598102,0.99560696,0.00037003064,0.00014380322,0.00009014841,0.000009072215,0.00005080936,0.000002395289,0.0024670248],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999254,0.000011686703,0.000011170125,0.000014447608,0.000030130273,0.0000071576114],"domain_scores_gemma":[0.99992275,0.000027554075,0.000013952836,0.0000029800656,0.000023006114,0.000009794901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022944609,0.0006786818,0.0010431166,0.0012868311,0.00026096878,0.0005427848,0.00050375384,0.0006022032,0.003001157],"category_scores_gemma":[0.00021958775,0.00019137163,0.00025950785,0.0011532838,0.00018828995,0.00069964485,0.00037844933,0.0008447579,0.0031628653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009470895,0.000070307055,0.00015237606,0.008084386,0.00006114799,0.0004128153,0.000054239306,0.0002806377,0.013002415,0.002357208,0.016603807,0.95882595],"study_design_scores_gemma":[0.000024260635,0.00019488884,0.0010117337,0.0012976361,0.000095600364,0.0025041602,0.00005936874,0.00007187894,0.0029426904,0.0009755294,0.9908035,0.000018732439],"about_ca_topic_score_codex":0.0005398173,"about_ca_topic_score_gemma":0.0013942961,"teacher_disagreement_score":0.003001157,"about_ca_system_score_codex":0.00031717084,"about_ca_system_score_gemma":0.0004749095,"threshold_uncertainty_score":0.010039866},"labels":[],"label_agreement":null},{"id":"W2056191807","doi":"10.1111/j.1527-3466.2004.tb00130.x","title":"Therapeutic Potentials of Sarpogrelate in Cardiovascular Disease*","year":2004,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Internal medicine; Cardiology; Pharmacology","score_opus":0.048073908872342815,"score_gpt":0.30751698357133367,"score_spread":0.25944307469899086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056191807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073858013,0.99597245,0.0001564519,0.0001816486,0.00012102229,0.000009856892,0.000017971415,0.000010676254,0.0027913363],"genre_scores_gemma":[0.0029732198,0.99464405,0.00033111,0.00020573798,0.00015881438,0.000013909919,0.000048981878,0.0000018842163,0.0016222914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990654,0.000020170279,0.000012567813,0.000015568437,0.000036209374,0.000008964174],"domain_scores_gemma":[0.99992275,0.000031987987,0.000014936623,0.000003109447,0.000018169661,0.000009163103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029545894,0.0006089087,0.0008925186,0.0015104638,0.00023404788,0.0005010702,0.00046800944,0.00079796155,0.0040850597],"category_scores_gemma":[0.0002166093,0.0001669058,0.00028559825,0.0011185532,0.00021101642,0.00061059435,0.0003166403,0.00091426336,0.0026824945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016793881,0.00015429858,0.00015829307,0.006558966,0.000052787527,0.0004929317,0.000057112644,0.00026366365,0.0074699903,0.0018069965,0.009407859,0.9734091],"study_design_scores_gemma":[0.0001004797,0.00051732804,0.0022074461,0.0022915576,0.000118508106,0.00494933,0.000076160184,0.00018718108,0.0029568374,0.0014421123,0.9851334,0.000019513722],"about_ca_topic_score_codex":0.00044980482,"about_ca_topic_score_gemma":0.0011766528,"teacher_disagreement_score":0.0040850597,"about_ca_system_score_codex":0.00023957218,"about_ca_system_score_gemma":0.00033102575,"threshold_uncertainty_score":0.013665915},"labels":[],"label_agreement":null},{"id":"W2058119912","doi":"10.1111/j.1527-3466.2004.tb00150.x","title":"SEA0400: A Novel Sodium‐Calcium Exchange Inhibitor with Cardioprotective Properties<sup>1</sup>","year":2004,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Calcium; Sodium-calcium exchanger; Pharmacology; Ischemia; Sodium; Chemistry; Calcium metabolism; Medicine; Internal medicine","score_opus":0.04865767773647853,"score_gpt":0.27789542583614085,"score_spread":0.22923774809966233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058119912","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5998625,0.3176559,0.022920059,0.0018536673,0.0016205402,0.0005461507,0.0024064837,0.002161953,0.05097276],"genre_scores_gemma":[0.74631983,0.19554976,0.018848596,0.0032979518,0.00096592784,0.00047990313,0.006333172,0.00016577324,0.02803918],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999583,0.000006351681,0.00000603819,0.0000072974913,0.000012803589,0.000009204831],"domain_scores_gemma":[0.999964,0.0000054513575,0.00001120784,0.0000020587681,0.0000064215174,0.000010823984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009642341,0.0007144841,0.0006040299,0.00040553222,0.00014695976,0.0003515886,0.00058363215,0.00050800835,0.0024292436],"category_scores_gemma":[0.00009548163,0.00012922578,0.00033252029,0.00034973022,0.00019086066,0.00040437316,0.00025852796,0.0007354541,0.0014555008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018590643,0.00062636856,0.0006551365,0.0015249342,0.00010092296,0.0012414001,0.00008305774,0.00088366587,0.69899035,0.0018636532,0.007822375,0.28434905],"study_design_scores_gemma":[0.0013304262,0.016015047,0.012162106,0.00026794925,0.00048378043,0.011879141,0.000106079664,0.0040678633,0.7026842,0.0007945084,0.25007996,0.00012895897],"about_ca_topic_score_codex":0.0001814797,"about_ca_topic_score_gemma":0.00031309156,"teacher_disagreement_score":0.0024292436,"about_ca_system_score_codex":0.00013345857,"about_ca_system_score_gemma":0.00019009568,"threshold_uncertainty_score":0.0081266165},"labels":[],"label_agreement":null},{"id":"W2059800971","doi":"10.1111/j.1527-3466.2003.tb00113.x","title":"Development of Novel Water‐Soluble Phytostanol Analogs: Disodium Ascorbyl Phytostanyl Phosphates (FM‐VP4): Preclinical Pharmacology, Pharmacokinetics and Toxicology","year":2003,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Natural Antidiabetic Agents Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacokinetics; Toxicity; In vivo; Cholesterol; Chemistry; Triglyceride; Pharmacology; Endocrinology; Internal medicine; Medicine; Biochemistry; Biology","score_opus":0.09291929609838748,"score_gpt":0.3728884157797718,"score_spread":0.27996911968138427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059800971","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984361,0.0041091694,0.0084756715,0.00019557467,0.000047132326,0.00031604018,0.0007282916,0.00019603927,0.0015711533],"genre_scores_gemma":[0.9818731,0.004047014,0.009322616,0.00009362103,0.000021990852,0.00021552549,0.0012511228,0.000028761682,0.0031463471],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999547,0.00000941173,0.000004226519,0.0000088535935,0.000010544429,0.000012427242],"domain_scores_gemma":[0.9999286,0.000010129853,0.000021313146,0.000006815496,0.000011186727,0.000021942607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001929407,0.00043845293,0.00032908365,0.00033679348,0.00010333767,0.0002041905,0.000356733,0.00038628577,0.0010968142],"category_scores_gemma":[0.00010422635,0.00018098787,0.00029341114,0.00020271116,0.00018209312,0.0002752563,0.00013605255,0.00064856326,0.00028750848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008102684,0.00034798429,0.00015437852,0.00011911088,0.000020812817,0.00008846439,0.000024218814,0.0007465368,0.9839887,0.0002042205,0.00012381522,0.01337149],"study_design_scores_gemma":[0.00034923622,0.007731758,0.0013624749,0.000010233364,0.00006579393,0.00028000647,0.000016836106,0.0012839414,0.9824468,0.000099578836,0.006339811,0.00001353387],"about_ca_topic_score_codex":0.0005634822,"about_ca_topic_score_gemma":0.0007365106,"teacher_disagreement_score":0.0010968142,"about_ca_system_score_codex":0.0002890076,"about_ca_system_score_gemma":0.00028594973,"threshold_uncertainty_score":0.0036692023},"labels":[],"label_agreement":null},{"id":"W2123132757","doi":"10.1111/j.1527-3466.2005.tb00175.x","title":"CGS 35601, a Triple Inhibitor of Angiotensin Converting Enzyme, Neutral Endopeptidase and Endothelin Converting Enzyme","year":2006,"lang":"en","type":"review","venue":"Cardiovascular Drug Reviews","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Adrenomedullin; Neprilysin; Bradykinin; Endocrinology; Internal medicine; Angiotensin-converting enzyme; Nitric oxide; Renin–angiotensin system; ACE inhibitor; Angiotensin II; Endothelin receptor; Vasodilation; Endothelins; Chemistry; Medicine; Pharmacology; Enzyme; Blood pressure; Biochemistry; Receptor","score_opus":0.04591030866929509,"score_gpt":0.2978938965282381,"score_spread":0.25198358785894304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123132757","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9382541,0.027415585,0.019960806,0.00048148056,0.00039820364,0.00043133262,0.0024264322,0.0016192824,0.009012746],"genre_scores_gemma":[0.9691235,0.008283179,0.013278712,0.00041718315,0.00008161902,0.00023611325,0.0028292388,0.000065253254,0.0056852307],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980885,0.000014689095,0.000020615735,0.00004232225,0.00006260498,0.000050953193],"domain_scores_gemma":[0.9998721,0.000008062492,0.00003713981,0.0000077500445,0.000011040084,0.000063801795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001176253,0.0007848914,0.00072721584,0.0005471681,0.0001747475,0.00031811628,0.00035685053,0.0004893533,0.0015988256],"category_scores_gemma":[0.00013360067,0.00018405096,0.0004194761,0.00033867403,0.00024042616,0.00025428535,0.00028269686,0.000989262,0.0009001181],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005700543,0.00014692397,0.00020953083,0.00015259066,0.000035385892,0.00011216864,0.000011355683,0.00017358064,0.98482853,0.00015363074,0.00049796805,0.013108229],"study_design_scores_gemma":[0.0008494007,0.005734729,0.0064145518,0.000028417773,0.0002558595,0.0022804346,0.000025294992,0.0019051121,0.9622857,0.00016921687,0.020011535,0.000039778257],"about_ca_topic_score_codex":0.0007246238,"about_ca_topic_score_gemma":0.0010567317,"teacher_disagreement_score":0.0015988256,"about_ca_system_score_codex":0.00031071802,"about_ca_system_score_gemma":0.00039665424,"threshold_uncertainty_score":0.005348623},"labels":[],"label_agreement":null},{"id":"W4241518501","doi":"10.1111/j.1527-3466.2002.tb00093.x","title":"Remembrance","year":2002,"lang":"pt","type":"article","venue":"Cardiovascular Drug Reviews","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Citation; Library science; Medicine; Computer science","score_opus":0.04276577490333623,"score_gpt":0.27032176406071773,"score_spread":0.2275559891573815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241518501","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002743381,0.0040821037,0.0044431686,0.027587285,0.05627552,0.00013308974,0.00059602497,0.0021521936,0.90198725],"genre_scores_gemma":[0.0044343583,0.0005360129,0.0005639953,0.002995771,0.003886379,0.00002281141,0.00017319624,0.00030949124,0.98707795],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869496,0.00022350626,0.00005983383,0.00017602382,0.0006749974,0.00017057204],"domain_scores_gemma":[0.9958061,0.0004556804,0.0002061212,0.0010613626,0.0014458435,0.0010248937],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015059866,0.0005835265,0.0004759913,0.0012501642,0.0017096375,0.004771559,0.0012251157,0.0018467437,0.37585357],"category_scores_gemma":[0.0075072297,0.0002787949,0.0005113707,0.0005635738,0.00079862564,0.0022161808,0.0029604337,0.0028356628,0.27391377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056163663,0.00004142979,0.00027231526,0.0000888993,0.0000047318795,0.00027288593,0.00027502095,0.000038714825,0.0016507568,0.011272735,0.84706736,0.1389589],"study_design_scores_gemma":[0.0000024491744,0.000010783154,0.00022053705,0.000020746633,0.0000011740492,0.00015892083,0.00004924509,0.000024515266,0.00020807316,0.0008512169,0.99844897,0.0000032816863],"about_ca_topic_score_codex":0.00078796543,"about_ca_topic_score_gemma":0.002153878,"teacher_disagreement_score":0.37585357,"about_ca_system_score_codex":0.0007223441,"about_ca_system_score_gemma":0.0015573878,"threshold_uncertainty_score":0.89026916},"labels":[],"label_agreement":null}]}